시장보고서
상품코드
2077768

혈관 내 미세축형 좌심실 보조장치 시장 보고서(2026년)

Intravascular Microaxial LVAD Devices Global Market Report 2026

발행일: | 리서치사: 구분자 The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 4,490 금액 안내 화살표 ₩ 6,689,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 금액 안내 화살표 ₩ 9,668,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 금액 안내 화살표 ₩ 12,648,000
※ 부가세 별도
한글목차
영문목차

혈관 내 미세축형 좌심실 보조장치 시장 규모는 최근 급성장하고 있습니다. 2025년 4억 5,000만 달러에서 2026년에는 5억 3,000만 달러로 확대되어, CAGR 17.5%로 성장할 전망입니다. 지난 몇 년간의 성장 요인으로는 중증 심부전 환자 수 증가, 심장 이식용 기증 심장공급 부족, 일시적인 기계적 순환 보조 장치의 도입 확대, 경피적 관상동맥 중재술(PCI) 시술의 보급 확대, 그리고 심장 카테터 검사실 인프라 확충 등을 들 수 있습니다.

혈관 내 미세축형 좌심실 보조장치 시장 규모는 향후 몇 년간 급성장이 전망되고 있습니다. 2030년까지 10억 2,000만 달러에 이르고, CAGR은 17.7%를 나타낼 전망입니다. 예측 기간 동안의 이러한 성장은 저침습형 심장 보조 솔루션에 대한 수요 증가, 심혈관 질환을 앓고 있는 고령 인구 증가, 단기 심실 보조 기술의 발전, 회복까지의 가교 요법에 대한 임상 현장의 선호도 증가, 그리고 전 세계 전문 심장 치료 센터의 확대에 기인한 것으로 보입니다. 예측 기간 동안의 주요 동향으로는 저침습 경피적 심실 보조 장치의 도입, 혈액과 호환되는 혈액 펌프 소재의 혁신, 초소형 축류 펌프의 소형화, 장기간에 걸친 기계적 순환 보조의 최적화, 카테터를 이용한 심장 중재술의 워크플로우 통합 등이 있습니다.

심혈관 질환 유병률 증가는 향후 몇 년 동안 혈관 내 미세축형 좌심실 보조장치 시장의 성장을 견인할 것으로 예측됩니다. 심혈관 질환이란 관상동맥 질환, 심부전, 뇌졸중, 고혈압 등 심혈관 기능을 손상시키고 지속적인 임상 관리가 필요한 심장 및 혈관 질환을 말합니다. 심혈관 질환 증가는 주로 고령화의 진행과 선진국에서 위험 요인의 유병률 상승에 기인합니다. 혈관 내 미세축형 좌심실 보조장치는 중증 심부전 환자에게 혈역학적 안정성을 제공하고, 회복, 이식 또는 만성적 지원으로의 가교 역할을 하는 첨단 순환 보조 솔루션을 제공함으로써 이러한 추세를 뒷받침하고 있습니다. 예를 들어, 2024년 1월, 미국에 본부를 둔 비영리 단체인 미국심장협회(American Heart Association)에 따르면, 심혈관 질환에 의한 연령 조정 사망률은 2023년 10만 명당 224.4에서 4.0% 증가하여 2024년에는 10만 명당 233.3에 달했습니다. 따라서 심혈관 질환 유병률 증가가 혈관 내 미세축형 좌심실 보조장치 시장의 성장을 주도하고 있습니다.

혈관 내 미세축형 좌심실 보조장치 시장에서 사업을 전개하는 주요 기업들은 9세대 '임펠라 CP(Impella CP)' 혈관 내 마이크로 축방향 유동 펌프 등 정밀한 심장 보조 기술의 발전에 주력하고 있습니다. 이를 통해 혈역학적 지원 강화, 환자 생존율 향상, 저침습적 고위험 심장 중재술의 실현, 그리고 실시간 심기능 모니터링의 최적화를 도모하고 있습니다. 9세대 '임펠라 CP' 혈관 내 마이크로 축류 펌프란, 경피적으로 심장에 삽입되는 소형화된 고효율 축류 펌프를 통해 좌심실의 부하를 경감하고 혈역학적 지원을 향상시키도록 설계된 첨단 카테터형 기계적 순환 보조 장치를 말합니다. 예를 들어, 2025년 10월, 미국에 본사를 둔 의료 기술 기업인 존슨앤드존슨 메드테크는 Transcatheter Cardiovascular Therapeutics(TCT) 2025 컨퍼런스에서 최신 임펠라 CP 및 장기 생존율에 관한 데이터를 발표했습니다. 최신 '임펠라 CP'는 혈역학적 지원을 강화하기 위한 펌프 기능 최적화, 임상의의 사용 편의성을 높이기 위한 설계 개선, 그리고 장기 생존율 향상을 입증하는 새로운 근거를 특징으로 합니다. 이러한 혁신은 심인성 쇼크나 고위험 경피적 시술에서 ‘임펠러’ 사용을 권장하는 최신 임상 지침과 부합하며, 그 적용 범위를 확대되고 있습니다. 비용이나 훈련 요건은 여전히 고려해야 할 사항이지만, 이러한 기기의 발전 덕분에 급성기 단계에서의 심장 지원 능력이 강화되고 있습니다.

자주 묻는 질문

  • 혈관 내 미세축형 좌심실 보조장치 시장 규모는 어떻게 변화하고 있나요?
  • 혈관 내 미세축형 좌심실 보조장치 시장의 성장 요인은 무엇인가요?
  • 심혈관 질환 유병률 증가는 혈관 내 미세축형 좌심실 보조장치 시장에 어떤 영향을 미치고 있나요?
  • 혈관 내 미세축형 좌심실 보조장치 시장에서 주요 기업들은 어떤 기술에 주력하고 있나요?
  • 9세대 '임펠라 CP' 혈관 내 마이크로 축류 펌프의 특징은 무엇인가요?

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향 및 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역 및 국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황 및 투자 환경

제36장 경쟁 구도 및 기업 개요

제37장 기타 주요 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹 및 대시보드

제39장 시장에서 주목 받는 스타트업

제40장 주요 인수합병(M&A)

제41장 시장 잠재력이 높은 국가, 부문, 전략

제42장 부록

KTH 26.07.13

Intravascular microaxial LVAD devices are minimally invasive mechanical circulatory support systems developed to aid the left ventricle in circulating blood throughout the body. They utilize a compact axial flow pump inserted via blood vessels to sustain cardiac output in cases of severe heart failure or during high-risk cardiac interventions. These devices deliver short-term hemodynamic assistance by enhancing blood flow and decreasing strain on the impaired heart.

The primary product types of intravascular microaxial LVAD devices include low flow devices less than 3 liters per minute, mid flow devices ranging from 3 to 4 liters per minute, and high flow devices greater than or equal to 4 liters per minute. Low flow devices less than 3 liters per minute refer to cardiac assist systems designed to provide limited circulatory support in early-stage or less severe cardiac conditions. These devices are categorized based on duration of support into ultra short term less than 24 hours, short term 1 to 3 days, and prolonged use more than 3 days up to 14 days, and are used in both adult and pediatric patient populations. The key applications include bridge to transplant, bridge to recovery, destination therapy, and high risk percutaneous coronary intervention, while end users include tertiary care hospitals, specialized heart and vascular centers, and academic and research hospitals.

Tariffs are affecting the intravascular microaxial LVAD devices market by increasing expenses for imported precision components, micro-scale pumps, and advanced biocompatible materials required for device production and assembly. This is driving up overall device costs and slowing adoption in advanced cardiac care environments, particularly in import-reliant regions such as Asia-Pacific and parts of Latin America. High-flow devices and bridge-to-transplant applications are most impacted due to dependence on globally sourced specialized components and complex supply chains. Nevertheless, tariffs are also stimulating localized medical device manufacturing, strengthening regional supplier networks, and boosting investment in domestic cardiovascular technology capabilities, which may improve long-term supply stability and cost predictability.

The intravascular microaxial LVAD devices market research report is one of a series of new reports from The Business Research Company that provides intravascular microaxial LVAD devices market statistics, including intravascular microaxial LVAD devices industry global market size, regional shares, competitors with a intravascular microaxial LVAD devices market share, detailed intravascular microaxial LVAD devices market segments, market trends and opportunities, and any further data you may need to thrive in the intravascular microaxial LVAD devices industry. This intravascular microaxial LVAD devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intravascular microaxial LVAD devices market size has grown rapidly in recent years. It will grow from $0.45 billion in 2025 to $0.53 billion in 2026 at a compound annual growth rate (CAGR) of 17.5%. The growth in the historic period can be attributed to rising prevalence of advanced heart failure cases, limited donor heart availability for transplantation, increasing adoption of temporary mechanical circulatory support, growing use of percutaneous coronary intervention procedures, expansion of cardiac catheterization laboratory infrastructure.

The intravascular microaxial LVAD devices market size is expected to see rapid growth in the next few years. It will grow to $1.02 billion by 2030 at a compound annual growth rate (CAGR) of 17.7%. The growth in the forecast period can be attributed to increasing demand for minimally invasive cardiac support solutions, rising geriatric population with cardiovascular disorders, advancement in short term ventricular assist technologies, growing clinical preference for bridge to recovery therapies, expansion of specialized cardiac care centers globally. Major trends in the forecast period include minimally invasive percutaneous ventricular support adoption, hemocompatible blood pump material innovation, ultra-compact axial flow pump miniaturization, extended duration mechanical circulatory support optimization, catheter based cardiac intervention workflow integration.

The increasing prevalence of cardiovascular diseases is anticipated to propel the growth of the intravascular microaxial LVAD devices market in coming years. Cardiovascular diseases refer to disorders of the heart and blood vessels, including coronary artery disease, heart failure, stroke, and hypertension, that impair cardiovascular function and require ongoing clinical management. The rise in cardiovascular diseases is driven mainly by aging populations and increasing prevalence of risk factors in developed economies. Intravascular microaxial LVAD devices supports this trend by providing advanced circulatory support solutions that stabilize hemodynamics and bridge patients to recovery, transplant, or chronic support in cases of severe heart failure. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024 up 4.0% from 224.4 per 100,000 in 2023. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the intravascular microaxial LVAD devices market.

Leading companies operating in the intravascular microaxial LVAD devices market are focusing on advancing precision cardiac support technologies, such as the ninth-generation Impella CP intravascular microaxial flow pump, to enhance hemodynamic support, improve patient survival outcomes, enable minimally invasive high-risk cardiac interventions, and optimize real-time cardiac performance monitoring. The ninth-generation Impella CP intravascular microaxial flow pump refers to an advanced catheter-based mechanical circulatory support device designed to provide enhanced left ventricular unloading and improved hemodynamic support through a miniaturized, high-efficiency axial flow pump inserted percutaneously into the heart. For example, in October 2025, Johnson & Johnson MedTech, a US-based medical technology company, highlighted the newest Impella CP and long-term survival data at the Transcatheter Cardiovascular Therapeutics (TCT) 2025 conference. The newest Impella CP features optimized pump functionality for enhanced hemodynamic support, design updates that improve ease of use for clinicians, and upgraded evidence showing improved long-term survival outcomes. These innovations align with updated clinical guidelines recommending Impella for cardiogenic shock and high-risk percutaneous procedures, expanding its applicability. While cost and training requirements remain considerations, these device advancements strengthen acute cardiac support capabilities.

The rising healthcare expenditure is anticipated to propel the growth of the intravascular microaxial LVAD devices market in coming years. Healthcare expenditure refers to the total amount of financial resources spent on health services, including hospital care, medical devices, physician services, and preventive care, to improve health outcomes. The increase in healthcare expenditure is driven by factors such as the growing prevalence of cardiovascular diseases and advancements in medical technologies that require higher investment. Intravascular microaxial LVAD devices are used to provide temporary mechanical circulatory support in patients with severe cardiac conditions, improving cardiac output and stabilizing hemodynamics during high-risk procedures or acute heart failure. Increased healthcare spending enables greater access to advanced cardiac care technologies, supports hospital adoption of innovative devices, and enhances patient affordability for life-saving treatments. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure experienced a significant rise of 5.6% in nominal terms from 2022 to 2023, marking a notable acceleration from the 0.9% growth recorded in 2022. Therefore, the rising healthcare expenditure is driving the growth of the intravascular microaxial LVAD devices market.

Major companies operating in the intravascular microaxial lvad devices market are Johnson & Johnson, Abbott Laboratories, Medtronic Plc, Supira Medical Inc. , Magenta Medical Ltd. , Jarvik Heart Inc. , Windmill Cardiovascular Systems Inc. , PulseCath B. V.

North America was the dominating region in the intravascular microaxial LVAD devices market in 2025. Asia-Pacific is expected to be the rapidly expanding region during the forecast period. The regions covered in the intravascular microaxial LVAD devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the intravascular microaxial LVAD devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The intravascular microaxial LVAD devices market consists of sales of catheter-based microaxial blood pumps, percutaneous ventricular assist devices, pump controllers and consoles, and related monitoring and support components. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intravascular Microaxial LVAD Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses intravascular microaxial lvad devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intravascular microaxial lvad devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intravascular microaxial lvad devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Low Flow Devices Less Than 3 Liters Per Minute; Mid Flow Devices 3 To 4 Liters Per Minute; High Flow Devices Greater Than Or Equal To 4 Liters Per Minute
  • 2) By Duration Of Support: Ultra Short Term Less Than 24 Hours; Short Term 1 To 3 Days; Prolonged More Than 3 Days Up To 14 Days
  • 3) By Patient Type: Adult; Pediatric
  • 4) By Application: Bridge To Transplant; Bridge To Recovery; Destination Therapy; High Risk Percutaneous Coronary Intervention
  • 5) By End User: Tertiary Care Hospitals; Specialized Heart And Vascular Centers; Academic And Research Hospitals
  • Subsegments:
  • 1) By Low Flow Devices Less Than 3 Liters Per Minute: Percutaneous Left Ventricular Assist Devices; Miniaturized Flow Left Ventricular Assist Devices; Hemocompatible Low Flow Devices; Temporary Support Left Ventricular Assist Devices; Wearable Low Flow Circulatory Support Devices
  • 2) By Mid Flow Devices 3 To 4 Liters Per Minute: Percutaneous Mid Flow Left Ventricular Assist Devices; Intermediate Flow Circulatory Support Devices; Compact Mid Flow Heart Pump Devices; Hemocompatible Mid Flow Left Ventricular Assist Devices; Transcatheter Mid Flow Ventricular Support Devices
  • 3) By High Flow Devices Greater Than Or Equal To 4 Liters Per Minute: Surgical High Flow Left Ventricular Assist Devices; Long Term High Flow Circulatory Support Devices; High Capacity Hemocompatible Left Ventricular Assist Devices; Wearable High Flow Heart Pump Devices; Transcatheter High Flow Ventricular Assist Devices
  • Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic Plc; Supira Medical Inc.; Magenta Medical Ltd.; Jarvik Heart Inc.; Windmill Cardiovascular Systems Inc.; PulseCath B.V.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Intravascular Microaxial LVAD Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Intravascular Microaxial LVAD Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Intravascular Microaxial LVAD Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Intravascular Microaxial LVAD Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Autonomous Systems, Robotics & Smart Mobility
  • 4.2. Major Trends
    • 4.2.1 Minimally Invasive Percutaneous Ventricular Support Adoption
    • 4.2.2 Hemocompatible Blood Pump Material Innovation
    • 4.2.3 Ultra-Compact Axial Flow Pump Miniaturization
    • 4.2.4 Extended Duration Mechanical Circulatory Support Optimization
    • 4.2.5 Catheter Based Cardiac Intervention Workflow Integration

5. Intravascular Microaxial LVAD Devices Market Analysis Of End Use Industries

  • 5.1 Tertiary Care Hospitals
  • 5.2 Specialized Heart And Vascular Centers
  • 5.3 Academic And Research Hospitals
  • 5.4 Cardiac Catheterization Laboratories
  • 5.5 Other End Users

6. Intravascular Microaxial LVAD Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Intravascular Microaxial LVAD Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Intravascular Microaxial LVAD Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Intravascular Microaxial LVAD Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Intravascular Microaxial LVAD Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Intravascular Microaxial LVAD Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Intravascular Microaxial LVAD Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Intravascular Microaxial LVAD Devices Market Segmentation

  • 9.1. Global Intravascular Microaxial LVAD Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Low Flow Devices Less Than 3 Liters Per Minute, Mid Flow Devices 3 To 4 Liters Per Minute, High Flow Devices Greater Than Or Equal To 4 Liters Per Minute
  • 9.2. Global Intravascular Microaxial LVAD Devices Market, Segmentation By Duration Of Support, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Ultra Short Term Less Than 24 Hours, Short Term 1 To 3 Days, Prolonged More Than 3 Days Up To 14 Days
  • 9.3. Global Intravascular Microaxial LVAD Devices Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Adult, Pediatric
  • 9.4. Global Intravascular Microaxial LVAD Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bridge To Transplant, Bridge To Recovery, Destination Therapy, High Risk Percutaneous Coronary Intervention
  • 9.5. Global Intravascular Microaxial LVAD Devices Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Tertiary Care Hospitals, Specialized Heart And Vascular Centers, Academic And Research Hospitals
  • 9.6. Global Intravascular Microaxial LVAD Devices Market, Sub-Segmentation Of Low Flow Devices Less Than 3 Liters Per Minute, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Percutaneous Left Ventricular Assist Devices, Miniaturized Flow Left Ventricular Assist Devices, Hemocompatible Low Flow Devices, Temporary Support Left Ventricular Assist Devices, Wearable Low Flow Circulatory Support Devices
  • 9.7. Global Intravascular Microaxial LVAD Devices Market, Sub-Segmentation Of Mid Flow Devices 3 To 4 Liters Per Minute, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Percutaneous Mid Flow Left Ventricular Assist Devices, Intermediate Flow Circulatory Support Devices, Compact Mid Flow Heart Pump Devices, Hemocompatible Mid Flow Left Ventricular Assist Devices, Transcatheter Mid Flow Ventricular Support Devices
  • 9.8. Global Intravascular Microaxial LVAD Devices Market, Sub-Segmentation Of High Flow Devices Greater Than Or Equal To 4 Liters Per Minute, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Surgical High Flow Left Ventricular Assist Devices, Long Term High Flow Circulatory Support Devices, High Capacity Hemocompatible Left Ventricular Assist Devices, Wearable High Flow Heart Pump Devices, Transcatheter High Flow Ventricular Assist Devices

10. Intravascular Microaxial LVAD Devices Market Regional And Country Analysis

  • 10.1. Global Intravascular Microaxial LVAD Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Intravascular Microaxial LVAD Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Intravascular Microaxial LVAD Devices Market

  • 11.1. Asia-Pacific Intravascular Microaxial LVAD Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Intravascular Microaxial LVAD Devices Market, Segmentation By Product Type, Segmentation By Duration Of Support, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Intravascular Microaxial LVAD Devices Market

  • 12.1. China Intravascular Microaxial LVAD Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Intravascular Microaxial LVAD Devices Market, Segmentation By Product Type, Segmentation By Duration Of Support, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Intravascular Microaxial LVAD Devices Market

  • 13.1. India Intravascular Microaxial LVAD Devices Market, Segmentation By Product Type, Segmentation By Duration Of Support, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Intravascular Microaxial LVAD Devices Market

  • 14.1. Japan Intravascular Microaxial LVAD Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Intravascular Microaxial LVAD Devices Market, Segmentation By Product Type, Segmentation By Duration Of Support, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Intravascular Microaxial LVAD Devices Market

  • 15.1. Australia Intravascular Microaxial LVAD Devices Market, Segmentation By Product Type, Segmentation By Duration Of Support, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Intravascular Microaxial LVAD Devices Market

  • 16.1. Indonesia Intravascular Microaxial LVAD Devices Market, Segmentation By Product Type, Segmentation By Duration Of Support, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Intravascular Microaxial LVAD Devices Market

  • 17.1. South Korea Intravascular Microaxial LVAD Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Intravascular Microaxial LVAD Devices Market, Segmentation By Product Type, Segmentation By Duration Of Support, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Intravascular Microaxial LVAD Devices Market

  • 18.1. Taiwan Intravascular Microaxial LVAD Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Intravascular Microaxial LVAD Devices Market, Segmentation By Product Type, Segmentation By Duration Of Support, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Intravascular Microaxial LVAD Devices Market

  • 19.1. South East Asia Intravascular Microaxial LVAD Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Intravascular Microaxial LVAD Devices Market, Segmentation By Product Type, Segmentation By Duration Of Support, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Intravascular Microaxial LVAD Devices Market

  • 20.1. Western Europe Intravascular Microaxial LVAD Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Intravascular Microaxial LVAD Devices Market, Segmentation By Product Type, Segmentation By Duration Of Support, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Intravascular Microaxial LVAD Devices Market

  • 21.1. UK Intravascular Microaxial LVAD Devices Market, Segmentation By Product Type, Segmentation By Duration Of Support, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Intravascular Microaxial LVAD Devices Market

  • 22.1. Germany Intravascular Microaxial LVAD Devices Market, Segmentation By Product Type, Segmentation By Duration Of Support, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Intravascular Microaxial LVAD Devices Market

  • 23.1. France Intravascular Microaxial LVAD Devices Market, Segmentation By Product Type, Segmentation By Duration Of Support, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Intravascular Microaxial LVAD Devices Market

  • 24.1. Italy Intravascular Microaxial LVAD Devices Market, Segmentation By Product Type, Segmentation By Duration Of Support, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Intravascular Microaxial LVAD Devices Market

  • 25.1. Spain Intravascular Microaxial LVAD Devices Market, Segmentation By Product Type, Segmentation By Duration Of Support, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Intravascular Microaxial LVAD Devices Market

  • 26.1. Eastern Europe Intravascular Microaxial LVAD Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Intravascular Microaxial LVAD Devices Market, Segmentation By Product Type, Segmentation By Duration Of Support, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Intravascular Microaxial LVAD Devices Market

  • 27.1. Russia Intravascular Microaxial LVAD Devices Market, Segmentation By Product Type, Segmentation By Duration Of Support, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Intravascular Microaxial LVAD Devices Market

  • 28.1. North America Intravascular Microaxial LVAD Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Intravascular Microaxial LVAD Devices Market, Segmentation By Product Type, Segmentation By Duration Of Support, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Intravascular Microaxial LVAD Devices Market

  • 29.1. USA Intravascular Microaxial LVAD Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Intravascular Microaxial LVAD Devices Market, Segmentation By Product Type, Segmentation By Duration Of Support, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Intravascular Microaxial LVAD Devices Market

  • 30.1. Canada Intravascular Microaxial LVAD Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Intravascular Microaxial LVAD Devices Market, Segmentation By Product Type, Segmentation By Duration Of Support, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Intravascular Microaxial LVAD Devices Market

  • 31.1. South America Intravascular Microaxial LVAD Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Intravascular Microaxial LVAD Devices Market, Segmentation By Product Type, Segmentation By Duration Of Support, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Intravascular Microaxial LVAD Devices Market

  • 32.1. Brazil Intravascular Microaxial LVAD Devices Market, Segmentation By Product Type, Segmentation By Duration Of Support, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Intravascular Microaxial LVAD Devices Market

  • 33.1. Middle East Intravascular Microaxial LVAD Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Intravascular Microaxial LVAD Devices Market, Segmentation By Product Type, Segmentation By Duration Of Support, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Intravascular Microaxial LVAD Devices Market

  • 34.1. Africa Intravascular Microaxial LVAD Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Intravascular Microaxial LVAD Devices Market, Segmentation By Product Type, Segmentation By Duration Of Support, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Intravascular Microaxial LVAD Devices Market Regulatory and Investment Landscape

36. Intravascular Microaxial LVAD Devices Market Competitive Landscape And Company Profiles

  • 36.1. Intravascular Microaxial LVAD Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Intravascular Microaxial LVAD Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Intravascular Microaxial LVAD Devices Market Company Profiles
    • 36.3.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Supira Medical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Magenta Medical Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Intravascular Microaxial LVAD Devices Market Other Major And Innovative Companies

  • Jarvik Heart Inc., Windmill Cardiovascular Systems Inc., PulseCath B.V.

38. Global Intravascular Microaxial LVAD Devices Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Intravascular Microaxial LVAD Devices Market

41. Intravascular Microaxial LVAD Devices Market High Potential Countries, Segments and Strategies

  • 41.1 Intravascular Microaxial LVAD Devices Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Intravascular Microaxial LVAD Devices Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Intravascular Microaxial LVAD Devices Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기